10:16 AM EST - Cipher Pharmaceuticals Inc. : Announces the signing of a definitive asset purchase agreement with ParaPRO LLC and the closing of the acquisition of the global product rights for Natroba™ (Spinosad), as well as the commercial sales team in the United States for total consideration of US$89.5 million. Cipher Pharmaceuticals Inc.
shares T.CPH are trading up $1.93 at $10.61.
